ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin (R)) for neovascular age-related macular degeneration
Author(s): Rosenfeld PJ, Moshfeghi AA, Puliafito CA
Source: OPHTHALMIC SURGERY LASERS & IMAGING    Volume: 36    Issue: 4    Pages: 331-335    Published: JUL-AUG 2005  
Times Cited: 309     References: 10     
Abstract: To determine whether intravitreal bevacizumab could improve optical coherence tomography and visual acuity outcomes in a patient with neovascular age-related macular degeneration who was responding poorly to pegaptanib therapy, an intravitreal injection of bevacizumab (1.0 mg) was given. Within 1 week, optical coherence tomography revealed resolution of the subretinal fluid, resulting in a normal-appearing macular contour. The improved macular appearance was maintained for at least 4 weeks, and visual acuity remained stable. No inflammation was observed. An intravitreal injection of bevacizumab may provide an effective, safe, and inexpensive option for patients with age-related macular degeneration who are losing vision secondary to macular neovascularization.
Document Type: Article
Language: English
Reprint Address: Rosenfeld, PJ (reprint author), Univ Miami, Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, 900 NW 17th St, Miami, FL 33136 USA
Addresses:
1. Univ Miami, Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA
Publisher: SLACK INC, 6900 GROVE RD, THOROFARE, NJ 08086 USA
Subject Category: Ophthalmology; Surgery
IDS Number: 968DA
ISSN: 1082-3069
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo